← Every applicant
Somerset FDA Approvals
12 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| OLOPATADINE HYDROCHLORIDENew drugDec 18, 2024SOLUTION/DROPS, OPHTHALMIC |
| CALCIUM CHLORIDE 10%New drugDec 17, 2024INJECTABLE, INJECTION |
| ZINC CHLORIDENew drugOct 16, 2024INJECTABLE, INJECTION |
| TIMOLOLNew drugOct 10, 2024SOLUTION/DROPS, OPHTHALMIC |
| DEXMEDETOMIDINE HYDROCHLORIDENew drugSep 24, 2024SOLUTION, INTRAVENOUS |
| BRIMONIDINE TARTRATE AND TIMOLOL MALEATENew drugSep 10, 2024SOLUTION/DROPS, OPHTHALMIC |
| OFLOXACINNew drugAug 1, 2024SOLUTION/DROPS, OPHTHALMIC |
| TIMOLOL MALEATENew drugJul 3, 2024SOLUTION/DROPS, OPHTHALMIC |
| CUPRIC CHLORIDENew drugApr 30, 2024INJECTABLE, INJECTION |
| ATROPINE SULFATENew drugApr 29, 2024SOLUTION/DROPS, OPHTHALMIC |
| BUPIVACAINE HYDROCHLORIDENew drugNov 20, 2023INJECTABLE, INJECTION |
| CALCIUM GLUCONATENew drugOct 19, 2023SOLUTION, INTRAVENOUS |